Buprenorphine sniffing as a response to inadequate care in substituted patients: Results from the Subazur survey in south-eastern France

Addictive Behaviors

Volumn 33, Issue 12, 2008, Pages 1625-1629

  Roux, Perrine ^a,b,c   Villes, Virginie ^a,b,c   Bry, Didier ^e   Spire, Bruno ^a,b,c   Feroni, Isabelle ^a,c,d   Marcellin, Fabienne ^a,b,c   Carrieri, M Patrizia ^a,b,c  

^a AIX MARSEILLE UNIV   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c OBSERVATOIRE RÉGIONAL DE LA SANTÉ PROVENCE ALPES CÔTE D AZUR   (France)

^d UNIVERSITÉ CÔTE D'AZUR   (France)

^e Réseau de santé toxicomanie du Vaucluse Retox 84 ^*  (France)

Author keywords

Buprenorphine; Diversion; Opioid substitution treatment; Primary care; Sniffing

Indexed keywords

BUPRENORPHINE;

ADULT; ARTICLE; DRUG DEPENDENCE; DRUG SAFETY; FEMALE; FRANCE; GENERALIZED ESTIMATING EQUATION; HUMAN; INTERVIEW; LOGISTIC REGRESSION ANALYSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL ANALYSIS; MULTIVARIATE ANALYSIS; OPIATE ADDICTION; PRIMARY MEDICAL CARE; RISK ASSESSMENT; RISK FACTOR; SINGLE PARENT; SNIFFING; TELEPHONE; TREATMENT REFUSAL;

ADMINISTRATION, INTRANASAL; ADULT; ANALGESICS, OPIOID; BUPRENORPHINE; FEMALE; FRANCE; HUMANS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; OPIOID-RELATED DISORDERS; PRIMARY HEALTH CARE; RISK FACTORS;

EID: 53049093140     PISSN: 03064603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addbeh.2008.07.018     Document Type: Article

References (23)

1. Barrio G., De La Fuente L., Lew C., Royuela L., Bravo M.J., and Torrens M. Differences in severity of heroin dependence by route of administration: The importance of length of heroin use. Drug and Alcohol Dependence 63 2 (2001) 169-177
2. Blaise G., Vanhooteghem O., and de la Brassinne M. Cocaine sniffing-induced lesions. Journal of the European Academy of Dermatology and Venereology 21 9 (2007) 1262-1263
3. Carlin J.B., Wolfe R., Coffey C., and Patton G.C. Analysis of binary outcomes in longitudinal studies using weighted estimating equations and discrete-time survival methods: Prevalence and incidence of smoking in an adolescent cohort. Statistics in Medicine 18 19 (1999) 2655-2679
4. Cicchetti D., and Toth S.L. Child maltreatment. Annual Review of Clinical Psychology 1 (2005) 409-438
5. Cicero T.J., Dart R.C., Inciardi J.A., Woody G.E., Schnoll S., and Munoz A. The development of a comprehensive risk-management program for prescription opioid analgesics: Researched abuse, diversion and addiction-related surveillance (RADARS). Pain Medicine 8 2 (2007) 157-170
6. Decelle L., Cosyns J.P., Georges B., Jadoul M., and Lefebvre C. Acute interstitial nephritis after cocaine sniffing. Clinical Nephrology 67 2 (2007) 105-108
7. Duburcq A., Charpak Y., Blin P., and Madec L. [Two years follow-up of a heroin users cohort treated with high dosage buprenorphine. Results of the SPESUB study (pharmacoepidemiologic follow-up of general practice Subutex)]. Revue d'Epidemiologie et de Sante Publique 48 4 (2000) 363-373
8. Eaves C.S. Heroin use among female adolescents: The role of partner influence in path of initiation and route of administration. American Journal of Drug and Alcohol Abuse 30 1 (2004) 21-38
9. Frank B. An overview of heroin trends in New York City: Past, present and future. Mount Sinai Journal of Medicine 67 5-6 (2000) 340-346
10. Fuhrer R., Rouillon F., and Lellouch J. Diagnostic reliability among French psychiatrists using DSM-III criteria. Acta Psychiatrica Scandinavica 73 1 (1986) 12-16
11. Koblin B.A., Factor S.H., Wu Y., and Vlahov D. Hepatitis C virus infection among noninjecting drug users in New York City. Journal of Medical Virology 70 3 (2003) 387-390
12. Kosten T.A., Miserendino M.J., and Kehoe P. Enhanced acquisition of cocaine self-administration in adult rats with neonatal isolation stress experience. Brain Research 875 1-2 (2000) 44-50
13. Mayfield D., McLeod G., and Hall P. The CAGE questionnaire: Validation of a new alcoholism screening instrument. American Journal of Psychiatry 131 10 (1974) 1121-1123
14. Roux P., Villes V., Blanche J., Bry D., Spire B., Feroni I., and Carrieri M.P. Buprenorphine in primary care: Risk factors for treatment injection and implications for clinical management. Drug and Alcohol Dependence (2008) 10.1016/j.drugalcdep.2008.03.025
15. Schottenfeld R.S., Chawarski M.C., Pakes J.R., Pantalon M.V., Carroll K.M., and Kosten T.R. Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence. American Journal of Psychiatry 162 2 (2005) 340-349
16. Stimmel B. Buprenorphine misuse, abuse, and diversion: When will we ever learn?. Journal of Addictive Diseases 26 3 (2007) 1-3
17. Strain E.C., Stitzer M.L., Liebson I.A., and Bigelow G.E. Comparison of buprenorphine and methadone in the treatment of opioid dependence. American Journal of Psychiatry 151 7 (1994) 1025-1030
18. Strang J. Abuse of buprenorphine (Temgesic) by snorting. BMJ 302 6782 (1991) 969
19. Van Ameijden E.J., and Coutinho R.A. Large decline in injecting drug use in Amsterdam, 1986-1998: Explanatory mechanisms and determinants of injecting transitions. Journal of Epidemiology and Community Health 55 5 (2001) 356-363
20. Verthein U., Haasen C., Prinzleve M., Degkwitz P., and Krausz M. Cocaine use and the utilisation of drug help services by consumers of the open drug scene in Hamburg. European Addiction Research 7 4 (2001) 176-183
21. Vidal-Trecan G., Varescon I., Nabet N., and Boissonnas A. Intravenous use of prescribed sublingual buprenorphine tablets by drug users receiving maintenance therapy in France. Drug and Alcohol Dependence 69 2 (2003) 175-181
22. Vignau J., Duhamel A., Catteau J., Legal G., Pho A.H., Grailles I., Beauvillain J., Petit P., Beauvillain P., and Parquet P.J. Practice-based buprenorphine maintenance treatment (BMT): How do French healthcare providers manage the opiate-addicted patients?. Journal of Substance Abuse Treatment 21 3 (2001) 135-144
23. Zeger S.L., and Liang K.Y. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42 1 (1986) 121-130